# Padagis LLC clinical trials: 37 on ClinicalTrials.gov (2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 37 trials with Padagis LLC as lead sponsor, 0 of them recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Clinical trials led by Padagis LLC: 37 rows for $5, every trial on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/company/padagis-llc

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 37
- Recruiting or not yet: 0
- Read on: November 19, 2026

## Trials

The 25 newest of 37, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| March 10, 2023 | NCT05763082 | Bioequivalence Study of Two Treatments for the Treatment of Plaque Psoriasis | Padagis LLC | Phase 3 | Completed | Plaque Psoriasis | 416 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05763082) |
| June 29, 2021 | NCT04944290 | To Compare the Efficacy and Safety of Perrigo's Product to an FDA Approved Product for the Treatment of Glaucoma or Ocular Hypertension in... | Padagis LLC | Phase 3 | Completed | Glaucoma, Open-Angle, Ocular Hypertension | 447 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04944290) |
| November 7, 2019 | NCT04155203 | To Compare the Safety and Efficacy of Perrigo's Product to an FDA Approved Product for the Treatment of Secondarily Infected Traumatic Skin... | Padagis LLC | Phase 3 | Completed | Secondarily Infected Traumatic Skin Lesions | 657 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04155203) |
| July 18, 2019 | NCT04024072 | To Compare the Safety and Efficacy of Perrigo's Product to an FDA Approved Product for the Treatment of Glaucoma or Ocular Hypertension in... | Padagis LLC | Phase 3 | Completed | Glaucoma, Open-Angle, Ocular Hypertension | 495 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04024072) |
| January 8, 2018 | NCT03393494 | Bioequivalence Study of Two Treatments in the Treatment of Acne Vulgaris on the Face | Padagis LLC | Phase 3 | Completed | Acne Vulgaris | 825 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03393494) |
| November 24, 2017 | NCT03352323 | An Evaluation of the Reduction in Erythema in Adult Patients With Moderate to Severe Persistent Facial Erythema Associated With Rosacea | Padagis LLC | Phase 3 | Completed | Rosacea, Erythema | 50 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03352323) |
| June 15, 2016 | NCT02800824 | Bioequivalence Study of Budesonide Rectal Aerosol Foam and Uceris® Rectal Aerosol Foam | Padagis LLC | Phase 1 | Completed | Healthy | Not listed | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02800824) |
| June 15, 2016 | NCT02800148 | Bioequivalence Study of Two Treatments in the Treatment of Inflammatory Lesions of Rosacea on the Face | Padagis LLC | Phase 3 | Completed | Rosacea | 667 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02800148) |
| June 9, 2016 | NCT02795117 | Comparative Safety and Efficacy of Two Treatments in the Treatment of Inflammatory Lesions of Rosacea | Padagis LLC | Phase 3 | Completed | Rosacea | 486 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02795117) |
| May 12, 2016 | NCT02770365 | Comparative Safety and Efficacy of Two Treatments in the Treatment of Vulvar and Vaginal Atrophy | Padagis LLC | Phase 3 | Completed | Atrophy | 695 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02770365) |
| August 17, 2015 | NCT02525549 | Comparative Safety and Bioequivalence of Two Treatments in the Treatment of Acne Vulgaris | Padagis LLC | Phase 3 | Completed | Acne | 903 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02525549) |
| August 4, 2015 | NCT02515305 | Comparative Safety and Efficacy of Two Treatments in the Treatment of Acne Vulgaris | Padagis LLC | Phase 3 | Completed | Acne | 890 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02515305) |
| June 2, 2015 | NCT02459795 | To Compare Safety and Efficacy of Perrigo's Drug Compared to an FDA Approved Drug in the Treatment of Actinic Keratosis | Padagis LLC | Phase 3 | Completed | Actinic Keratosis | 469 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02459795) |
| March 11, 2015 | NCT02385318 | To Compare Safety and Efficacy of Perrigo's Drug Product Compared to an FDA Approved Drug Product in the Treatment of Actinic Keratosis | Padagis LLC | Phase 3 | Completed | Actinic Keratosis | 519 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02385318) |
| March 11, 2015 | NCT02385240 | Comparative Safety and Efficacy of Two Rosacea Products in the Treatment of Facial Erythema of Rosacea | Padagis LLC | Phase 3 | Completed | Rosacea | 552 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02385240) |
| October 16, 2014 | NCT02265913 | Comparative Safety and Efficacy of Two Antiviral Treatments in the Treatment of Recurrent Herpes Simplex Labialis | Padagis LLC | Phase 3 | Completed | Herpes Labialis | 4,076 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02265913) |
| September 3, 2014 | NCT02230696 | Comparative Safety and Efficacy of Two Steroid Treatments in the Relief of the Symptoms of Seasonal Allergic Rhinitis | Padagis LLC | Phase 3 | Completed | Seasonal Allergic Rhinitis | 951 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02230696) |
| February 22, 2013 | NCT01796665 | A Study to Compare Clindamycin Phosphate and Benzoyl Peroxide Topical Gel 1.2%/2.5% to Acanya® Topical Gel in the Treatment of Acne Vulgaris | Padagis LLC | Phase 3 | Completed | Acne | 1,180 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01796665) |
| August 28, 2012 | NCT01673659 | A Safety and Bioequivalence of a Mometasone Nasal Spray, 50 mcg/Actuation Compared With Nasonex® Nasal Spray 50 mcg/Actuation in the Relief... | Padagis LLC | Phase 3 | Completed | Seasonal Allergic Rhinitis | 1,220 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01673659) |
| October 18, 2011 | NCT01453946 | Safety and Maintenance Study of Entocort for Children With Crohn's Disease | Padagis LLC | Phase 3 | Completed | Crohn's Disease | 55 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01453946) |
| September 30, 2011 | NCT01444092 | Safety Study of Entocort for Children With Crohn's Disease | Padagis LLC | Phase 3 | Completed | Crohn's Disease | 123 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01444092) |
| June 7, 2010 | NCT01138514 | Clinical Study Between Two Clindamycin 1%/Benzoyl Peroxide 5% Topical Gels | Padagis LLC | Phase 3 | Completed | Acne Vulgaris | 1,555 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01138514) |
| January 7, 2010 | NCT01044264 | Clinical Study Between Two 1% Clindamycin/5% Benzoyl Peroxide Topical Gel Formulations | Padagis LLC | Not applicable | Completed | Acne Vulgaris | 602 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01044264) |
| December 25, 2009 | NCT01039584 | A Randomized Study Evaluating the Therapeutic Equivalence of Two Butoconazole Nitrate Vaginal Cream, 2% Formulations | Padagis LLC | Not applicable | Completed | Vulvovaginal Candidiasis | 611 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01039584) |
| October 9, 2009 | NCT00992472 | Bioavailability of Prochlorperazine Suppositories, 25 mg | Padagis LLC | Phase 1 | Completed | Healthy | 42 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00992472) |

## By phase

| Phase | Trials |
| --- | --- |
| Phase 1 | 3 |
| Phase 3 | 22 |
| Not applicable | 5 |
| Observational | 7 |

## By status

| Status | Trials |
| --- | --- |
| Completed | 37 |

## Conditions

| Condition group | Trials |
| --- | --- |
| Acne Vulgaris | 6 |
| Rosacea | 4 |
| Crohn Disease | 2 |
| Candidiasis, Vulvovaginal | 2 |
| Tinea Pedis | 2 |
| Rhinitis, Allergic, Seasonal | 2 |
| Glaucoma, Open-Angle | 2 |
| Ocular Hypertension | 2 |
| Keratosis, Actinic | 2 |
| Atrophy | 1 |
| Candidiasis | 1 |
| Erythema | 1 |
| Herpes Labialis | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Granite suppliers in the United States](https://specstream.ai/data/businesses/granite-suppliers/united-states)
- [Child care centers in the United States](https://specstream.ai/data/businesses/child-care-centers/united-states)
- [Waterproofing contractors in the United States](https://specstream.ai/data/businesses/waterproofing-contractors/united-states)
- [Private equity firms in the United States](https://specstream.ai/data/businesses/private-equity-firms/united-states)
- [International fusion restaurants in the United States](https://specstream.ai/data/businesses/international-fusion-restaurants/united-states)
- [Diners in the United States](https://specstream.ai/data/businesses/diners/united-states)
